{"DataElement":{"publicId":"5527597","version":"1","preferredName":"Immune Dysregulation Type","preferredDefinition":"Text name to identify a category of immune dysregulation.","longName":"IMMUN_DYSREG_TP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"5527587","version":"1","preferredName":"Immune Dysregulation Identification","preferredDefinition":"A disorder resulting from an abnormality in the immune system._The procedure of having an identity established.","longName":"2716886v1.0:2322316v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2716886","version":"1","preferredName":"Immune System Disorder","preferredDefinition":"A disorder resulting from an abnormality in the immune system. -- 2003","longName":"C3507","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune System Disorder","conceptCode":"C3507","definition":"A disorder resulting from an abnormality in the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41D26659-B10F-23DA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-12-21","modifiedBy":"ONEDATA","dateModified":"2007-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2322316","version":"1","preferredName":"Identified","preferredDefinition":"Identified; having the identity known or established.","longName":"C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-0624-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-03","modifiedBy":"ONEDATA","dateModified":"2005-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F37C10C-BFF9-2168-E053-F662850AC503","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunosuppression CRF template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5527594","version":"1","preferredName":"Immune Dysregulation Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"IMM_DYSREG_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Granuloma formation","valueDescription":"Granuloma Formation","ValueMeaning":{"publicId":"5527595","version":"1","preferredName":"Granuloma Formation","longName":"5527595","preferredDefinition":"The act of forming something or the structure formed.: An inflammatory reaction usually caused by infectious organisms, foreign bodies, or cholesterol deposits. It is characterized by the presence of epithelioid histiocytes and chronic inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Formation","conceptCode":"C25513","definition":"The act of forming something or the structure formed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Granuloma","conceptCode":"C3064","definition":"An inflammatory reaction usually caused by infectious organisms, foreign bodies, or cholesterol deposits. It is characterized by the presence of epithelioid histiocytes and chronic inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F398FDB-1301-3260-E053-F662850A5E5F","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F398FDB-131A-3260-E053-F662850A5E5F","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"},{"value":"Splenomegaly","valueDescription":"Splenomegaly","ValueMeaning":{"publicId":"3626238","version":"1","preferredName":"Splenomegaly","longName":"3626238","preferredDefinition":"Splenomegaly is greater than 3 cm below left costal margin.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE67B082-9F3E-6F23-E040-BB89AD432628","latestVersionIndicator":"Yes","beginDate":"2012-11-13","endDate":null,"createdBy":"KNUTSOND","dateCreated":"2012-11-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F398FDB-1324-3260-E053-F662850A5E5F","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"},{"value":"HLH","valueDescription":"Hemophagocytic Lymphohistiocytosis","ValueMeaning":{"publicId":"5527596","version":"1","preferredName":"Hemophagocytic Lymphohistiocytosis","longName":"5527596","preferredDefinition":"A rare but potentially life-threatening disorder characterized by the proliferation of histiocytes and macrophages and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary, due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophagocytic Lymphohistiocytosis","conceptCode":"C34792","definition":"A rare, but potentially life-threatening disorder, characterized by the proliferation of histiocytes and macrophages, and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F398FDB-132F-3260-E053-F662850A5E5F","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F398FDB-1348-3260-E053-F662850A5E5F","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"},{"value":"Atopy","valueDescription":"Atopy","ValueMeaning":{"publicId":"5487973","version":"1","preferredName":"Atopy","longName":"5487973","preferredDefinition":"A genetic predisposition to form IgE antibodies in response to exposure to allergens and therefore, for the development of immediate (type I) hypersensitivity and atopic conditions, such as allergic rhinitis; bronchial asthma, atopic dermatitis, and food allergy. Mutations of specific alleles on the long arm of chromosome 5 have been associated with higher levels of IL-4 and IgE and are known as IL-4 promoter polymorphisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atopy","conceptCode":"C41366","definition":"A genetic predisposition to form IgE antibodies in response to exposure to allergens and therefore, for the development of immediate (type I) hypersensitivity and atopic conditions, such as allergic rhinitis; bronchial asthma, atopic dermatitis, and food allergy. Mutations of specific alleles on the long arm of chromosome 5 have been associated with higher levels of IL-4 and IgE and are known as IL-4 promoter polymorphisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D98BF0C-3714-100E-E053-F662850A6FED","latestVersionIndicator":"Yes","beginDate":"2016-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F398FDB-1352-3260-E053-F662850A5E5F","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F398FDB-12E9-3260-E053-F662850A5E5F","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunodeficiency CRF Template.  Value sets are prescribed for that specific set of requirements.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Immune dysregulation","type":"Preferred Question Text","description":"Immune dysregulation","url":null,"context":"CCR"}],"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F39CB70-5EA9-4F53-E053-F662850AA7DB","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}